MedPath

Diabetic Complications and Obstructive Sleep Apnea

Recruiting
Conditions
Diabetic Complications and Obstructive Sleep Apnea
Interventions
Other: regular treatment
Registration Number
NCT04646941
Lead Sponsor
The First Affiliated Hospital of Xiamen University
Brief Summary

To follow up the progress of chronic complications in T2DM patients who had undergone anthropometric measurements, laboratory testing and standard overnight polysomnography monitor from 2013 to 2018.

Detailed Description

Obstructive sleep apnea (OSA) is a common chronic sleep disorder and a frequent comorbidity in patients with type 2 diabetes. There has been increasing recognition that OSA is highly prevalent in persons with type 2 diabetes. This study is to explore the relationship between OSA and the progress of chronic diabetes-related complications in type 2 diabetes who had undergone anthropometric measurements, laboratory testing and standard overnight polysomnography monitor from 2013 to 2018 in the Department of Endocrinology and Diabetes, The First Affiliated Hospital of Xiamen University, Xiamen, China.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
330
Inclusion Criteria
  • Type 2 diabetes
  • Age:18-80
Exclusion Criteria
  • Patients with non type 2 diabetes mellitus
  • Preparation for pregnancy
  • Lactation patients
  • Patients with uncontrolled thyroid disease
  • Patients with severe cardiovascular disease
  • Patients with severe hepatic and renal insufficiency
  • Patients with oral and maxillofacial malformations and upper respiratory tract malformations
  • Patients with pulmonary infection or COPD
  • Patients who are not willing to accept the questionnaire survey
  • Unable to sign informed consent

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
T2DM without OSAregular treatmentType 2 diabetes patients without obstructive sleep apnea
T2DM with OSAregular treatmentType 2 diabetes patients with obstructive sleep apnea
Primary Outcome Measures
NameTimeMethod
the new onset and types of tumor in T2DM patientsFrom January 1, 2013 to December 31, 2020

the new onset and types of tumor in T2DM patients

the progress of diabetic complicationsFrom January 1, 2013 to December 31, 2020

Diabetic complications include diabetic microvascular complications, atherosclerotic cardiovascular disease(ASCVD), and Diabetic foot disease.

Diabetic microvascular complications include diabetic nephropathy, diabetic retinopathy and diabetic neuropathy.

Diabetic macrovascular complications refer to ASCVD, which is defined as coronary heart disease (CHD; acute and silent MI, and unstable angina), ischemic stroke, or peripheral artery disease (PAD).

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

The first affiliated hospital of Xiamen university

🇨🇳

Xiamen, Fujian, China

© Copyright 2025. All Rights Reserved by MedPath